Dr. Arati Rani Chand, MD

Dr. Chand practices at Adventist Health White Memorial in Los Angeles, California, part of Adventist Health.

Dr. Chand's NPI, 1942434212, was assigned on May 14, 2009. Dr. Chand graduated from Nalanda Medical College in 2005. Dr. Chand holds California license A121285.

Dr. Chand's primary practice is Adventist Health White Memorial, at 1720 Cesar E Chavez Avenue, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 268-5000.

Dr. Chand's primary practice is Adventist Health White Memorial in Los Angeles, California, part of Adventist Health. The medical group on file is Cancer & Blood Specialty Clinic. Dmand AI also links Dr. Chand to 1 more group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chand practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chand's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chand is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Chand's licenses on file in 2 states: California and Texas.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, deep vein thrombosis (DVT), lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Chand treats.

CMS data shows 3,685 Medicare services from Dr. Chand across 19 procedure codes in 2024, for 165 Medicare patients. Medicare paid $89,801 for them.

CMS counts 165 Medicare patients who saw Dr. Chand in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chand's median patient age at 66, with 62% women.

In 2024, Dr. Chand wrote 590 Medicare Part D claims for 150 patients. 61% of them were for generic drugs. CMS names the drug for 283 of them, across 13 drugs with 11 or more claims each, at $770,860 in total drug cost. In 2023, CMS named 395 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chand for performance year 2024, reported as part of a group. Dr. Chand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chand as offering telehealth.

Dmand AI links 1 paper to Dr. Chand in 2017.

Dmand AI links Dr. Chand to 3 clinical trials. Conditions studied include Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma and Triple Negative Breast Neoplasms.

CMS Open Payments shows 2,024 general payments to Dr. Chand from 100 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Novartis Pharmaceuticals Corporation paid the most, $29,802. It also lists 1 research payment totaling $883 in 2023.

Dr. Chand graduated from Nalanda Medical College in 2005.

Dr. Chand is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.